Related Experiment Videos
Modulation of Ly49 D expression after allogeneic bone marrow transplantation and functional consequences
Esther Wilk1, Simone Korten, Margot Zielinska-Skowronek
1Abteilung Klinische Immunologie, Medizinische Hochschule Hannover, Germany.
Immunobiology
|August 17, 2002
Summary
Natural killer (NK) cells adapt their Ly49 receptor repertoire following allogeneic bone marrow transplantation (BMT). This adaptation, involving Ly49 D and Ly49 G2 expression changes, leads to tolerance of host targets post-BMT.
Area of Science:
- Immunology
- Transplantation immunology
- NK cell biology
Background:
- Ly49 receptors on NK cells interact with MHC class I molecules to differentiate self from non-self.
- Allogeneic bone marrow transplantation (BMT) involves transferring donor cells to a recipient with a different genetic makeup.
Purpose of the Study:
- To investigate the behavior of the activating receptor Ly49 D on NK cells after allogeneic BMT.
- To understand how NK cell receptor expression and function change in response to a new MHC environment.
Main Methods:
- Allogeneic BMT model using B6 bone marrow into BALB/c recipients.
- Flow cytometry to analyze Ly49 D, Ly49 G2, and Ly49 A expression on NK cells.
- Assessment of NK cell cytotoxicity against target cells.
Main Results:
- A significant reduction in Ly49 D+ NK cells and decreased Ly49 D expression density were observed post-BMT.
- Nonstochastic coexpression of Ly49 D and Ly49 G2 was noted, with Ly49 G2 expression remaining constant on Ly49 D+ NK cells.
- NK cell cytotoxicity was reduced in the initial two months post-BMT, followed by the development of tolerance to host-specific targets.
Conclusions:
- NK cells can modify their Ly49 receptor repertoire to adapt to the new MHC class I environment after allogeneic BMT.
- Downregulation of specific NK cell receptors, like Ly49 D, appears to be influenced by the presence of new MHC class I molecules.
- The observed changes in NK cell repertoire and function contribute to the development of tolerance in allogeneic chimeras.